TG
GILD icon

Tom Gayner’s Gilead Sciences GILD Stock Holding History

Tom Gayner’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-33,000
Closed -$2.49M – 141
2018
Q1 		$2.49M Hold
33,000
– – 0.05% 115
2017
Q4 		$2.36M Hold
33,000
– – 0.04% 119
2017
Q3 		$2.67M Hold
33,000
– – 0.05% 117
2017
Q2 		$2.34M Buy
33,000
+6,000
+22% +$399K 0.05% 121
2017
Q1 		$1.83M Buy
27,000
+13,000
+93% +$914K 0.04% 117
2016
Q4 		$1M Buy
+14,000
New +$1.04M 0.02% 120

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tom Gayner's GILD Position: Q2 2018 in Review

Tom Gayner sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 33,000 shares — an estimated $2.49M sold.

Tom Gayner first reported a position in GILD in Q4 2016 and held it in 6 quarters. The position peaked at $2.67M in Q3 2017. 1,523 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Tom Gayner reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Tom Gayner sold 33,000 Gilead Sciences shares in Q2 2018, an estimated $2.49M.
  • Tom Gayner first reported a position in Gilead Sciences in Q4 2016 and held it in 6 quarters.
  • Tom Gayner's Gilead Sciences position peaked at $2.67M in Q3 2017.
  • 1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Markel Group's 13F filing for Q2 2018, filed 3 Aug 2018.